Local Tucsonan Mariam Rana found the confidence through the KEYS Research Internship to champion research experiences for fellow undergraduate students at the University of Arizona.

Inspired by the creative potential of technology, Ash Black educates students and works with researchers on AI and extended technology at the University of Arizona.

On October 8, over 115 University of Arizona researchers gathered to network over posters, lightning talks, and refreshments in the Thomas W. Keating building of the BIO5 Institute.

Hannah Pizzato, a researcher at the U of A Health Sciences Center for Advanced Molecular and Immunological Therapies, works in BIO5 member Deepta Bhattacharya’s lab to develop a stem cell-based therapy for Type 1 diabetes.

BIO5 member Jonathan Lifshitz, a research professor of psychiatry at the University of Arizona College of Medicine – Phoenix, was appointed a member of the National Institute of Neurological Disorders and Stroke’s Neurological Sciences and Disorders study section initial review group at the National Institutes of Health.

Hanami Inagaki and Sam Rose Shawley will be working with public affairs team at the BIO5 Institute in marketing, communications, and event planning.

Congratulations to Erika Eggers, Lisa Elfring, Kirsten Limesand, Kathleen Rodgers, Janet Roveda, Lisa Shubitz, and Stacy Tecot on their awards.

BIO5 members Leslie Farland and John Ruiz are a part of a team at the the U of A Health Sciences and the Instituto Nacional de Salud Pública in Mexico using a $2.2 million National Institutes of Health grant to explore the link between infertility and long-term health issues among Hispanic women of Mexican heritage.

A record number of KEYS alumni presented their research as the biosciences community recognized Kelle Hyland for her outstanding leadership in science outreach and education.

BIO5 member Deepta Bhattacharya is shepherding a new era in immunology research as the inaugural executive director of the U of A Health Sciences Center for Advanced Molecular and Immunological Therapies.